1,3,3-三甲基吲哚-奈谔嗪
|
T161502-25g
|
≥98%(HPLC) |
27333-47-7 |
25g
|
¥ 4633.9
|
现货 |
阿拉丁 |
盐酸小檗胺
|
T134229-250mg
|
≥98% |
6078-17-7 |
250mg
|
¥ 249.9
|
现货 |
阿拉丁 |
Tobramycin sulfate
|
T133599-5g
|
≥98% |
79645-27-5 |
5g
|
¥ 390.9
|
现货 |
阿拉丁 |
Tobramycin sulfate
|
T133599-25g
|
≥98% |
79645-27-5 |
25g
|
¥ 1336.9
|
现货 |
阿拉丁 |
Tobramycin sulfate
|
T133599-1g
|
≥98% |
79645-27-5 |
1g
|
¥ 100.9
|
现货 |
阿拉丁 |
1-十三烷酰基-2-羟基-sn-甘油-3-磷酸胆碱
|
T130490-5mg
|
≥99% |
20559-17-5 |
5mg
|
¥ 739.9
|
现货 |
阿拉丁 |
苯甲唑啉盐酸盐
|
T129920-5g
|
≥99% |
59-97-2 |
5g
|
¥ 59.9
|
现货 |
阿拉丁 |
苯甲唑啉盐酸盐
|
T129920-25g
|
≥99% |
59-97-2 |
25g
|
¥ 178.9
|
现货 |
阿拉丁 |
苯甲唑啉盐酸盐
|
T129920-100g
|
≥99% |
59-97-2 |
100g
|
¥ 217.9
|
现货 |
阿拉丁 |
4-(6-甲氧基-2-萘)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶)-1H-咪唑
|
T129823-5mg
|
Moligand™, ≥97% |
948557-43-5 |
5mg
|
¥ 268.9
|
现货 |
阿拉丁 |
4-(6-甲氧基-2-萘)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶)-1H-咪唑
|
T129823-25mg
|
Moligand™, ≥97% |
948557-43-5 |
25mg
|
¥ 952.9
|
现货 |
阿拉丁 |
替米沙坦
|
T129239-500g
|
Moligand™, ≥98% |
144701-48-4 |
500g
|
¥ 2080.9
|
现货 |
阿拉丁 |
替米沙坦
|
T129239-25g
|
Moligand™, ≥98% |
144701-48-4 |
25g
|
¥ 140.9
|
现货 |
阿拉丁 |
曲安西龙
|
T129207-5g
|
Moligand™, ≥99% |
124-94-7 |
5g
|
¥ 880.9
|
现货 |
阿拉丁 |
曲安西龙
|
T129207-250mg
|
Moligand™, ≥99% |
124-94-7 |
250mg
|
¥ 133.9
|
现货 |
阿拉丁 |
曲安西龙
|
T129207-1g
|
Moligand™, ≥99% |
124-94-7 |
1g
|
¥ 319.9
|
现货 |
阿拉丁 |
托烷司琼
|
T127885-5g
|
Moligand™, ≥99% |
89565-68-4 |
5g
|
¥ 1039.9
|
现货 |
阿拉丁 |
托烷司琼
|
T127885-1g
|
Moligand™, ≥99% |
89565-68-4 |
1g
|
¥ 328.9
|
现货 |
阿拉丁 |
(±)-沙利度胺
|
T126856-100g
|
Moligand™, ≥98% |
50-35-1 |
100g
|
¥ 2677.9
|
现货 |
阿拉丁 |
TAK-700 (Orteronel),抑制剂
|
T126788-50mg
|
≥98% |
426219-18-3 |
50mg
|
¥ 3614.9
|
现货 |
阿拉丁 |
TAK-700 (Orteronel),抑制剂
|
T126788-10mg
|
≥98% |
426219-18-3 |
10mg
|
¥ 1296.9
|
现货 |
阿拉丁 |
曲西瑞宾
|
T126748-25mg
|
Moligand™, ≥99% |
35943-35-2 |
25mg
|
¥ 1519.9
|
现货 |
阿拉丁 |
曲西瑞宾
|
T126748-100mg
|
Moligand™, ≥99% |
35943-35-2 |
100mg
|
¥ 3818.9
|
现货 |
阿拉丁 |
他喹莫德
|
T125086-500mg
|
Moligand™, ≥98% |
254964-60-8 |
500mg
|
¥ 9999.9
|
现货 |
阿拉丁 |